Authors


Fred Gebhart

Latest:

Cataract, glaucoma collision sparks MIGS, other innovation

The 2017 Charles D. Kelman Lecture touched on three main areas-from the teaching of the phaco technique during the early years of phaco to use of phaco in glaucoma patients to the introduction of phaco to surgeons in developing countries.


Daniel H. Chang, MD

Latest:

Analyzing the visual, non-visual benefits of VLF IOLs

Daniel H. Chang, MD, shares data on a recent study involving a new violet light-filtering chromophore in a preclinical computer simulation testing and randomized clinical study.


John R. Burroughs, MD

Latest:

Facial anatomy key to optimal use of botulinum toxin

Botulinum toxin type A effect is usually seen 2 to 3 days following injection, with maximal effect at approximately 2 weeks. Touch-ups are not recommended until 2 weeks have passed.


David Roncone, OD

Latest:

Time to enhance re-treatment of LASIK overcorrections

The incidence of overcorrection after LASIK for myopia is low, but the results of re-treatment are variable. Re-treating often results in a shift back to myopia, leaving the patient unhappy. To improve the results of LASIK enhancement surgery, a new formula is warranted. In 1999, Drs. Lindstrom and co-workers noted that laser treatment achieved different effects in eyes with primary versus secondary hyperopia. They attributed this effect to dynamics of wound healing.


Philip C. Roholt, MD

Latest:

Time to enhance re-treatment of LASIK overcorrections

The incidence of overcorrection after LASIK for myopia is low, but the results of re-treatment are variable. Re-treating often results in a shift back to myopia, leaving the patient unhappy. To improve the results of LASIK enhancement surgery, a new formula is warranted. In 1999, Drs. Lindstrom and co-workers noted that laser treatment achieved different effects in eyes with primary versus secondary hyperopia. They attributed this effect to dynamics of wound healing.


Christopher Teng, MD

Latest:

Pioneer of ophthalmic plastic surgery followed his calling

Editor's Note: During the time I was a resident at Manhattan Eye, Ear and Throat Hospital (1969-1972), I had the good fortune to work with Byron Capleese Smith, MD. Those who knew him will never forget him, and those who were not able to know him will gain a small glimpse of his persona and his contributions, as written by Christopher Teng, MD. -Norman Medow, MD


John Samples, MD

Latest:

Preserved medications may have detrimental effects in glaucoma patients with concurrent OSD

Ocular surface disease (OSD) in patients with glaucoma is surprisingly common, yet it remains an under-recognized condition by eye-care specialists. Among patients with severe OSD, approximately two-thirds concurrently are afflicted with glaucoma (range, 42.9% to 88.4%).1 OSD encompasses a myriad of ocular conditions, including keratoconjunctivitis sicca.


Omesh P. Gupta, MD, MBA

Latest:

Intracameral entry of antibiotic ointment seen after cataract surgery

A 59-year-old male was referred for decreased vision and glare in his right eye 7 days after uneventful clear corneal (CC) phacoemulsification with IOL implantation. On postoperative day 1, his visual acuity was 20/25 in the affected eye. The anterior chamber reaction revealed 1+ cell and flare and the IOL was clear.


Monte S. Dirks, MD

Latest:

Not all hypotensive lipids act the same for individuals

The advantages of the hypotensive lipids bimatoprost (Lumigan, Allergan), latanoprost (Xalatan, Pfizer), and travoprost (Travatan, Alcon) over timolol 0.5% (Timoptic, Merck) have been conclusively demonstrated in phase III clinical trials. As a class, these therapies have been shown to reduce IOP and to reduce fluctuations of the diurnal curve significantly. Yet, it is important to understand that despite these commonalities, differences also exist. It is only in understanding these differences, and matching them clinically to the individual profile of the patient, that we can choose the right drug at the right time.


William L. Rich III, MD

Latest:

Where goeth the 110th Congress?

Any major changes in health care will reflect the inflluence of moderates on both sides of the aisle.


Steve Swalgen

Latest:

In-office versus wholesale labs

As more and more ophthalmologists choose to provide full-service patient care, including eyewear dispensing, the relevant and growing complexities to the choice between an in-office edging lab approach versus an off-site, wholesale finishing lab solution have become increasingly important.


Andrew Lee, MD

Latest:

Pigskins and perception: How neuro-ophthalmology influences NFL referees

Every football fan knows the scrutiny that NFL game officials are put under every game day, and now a group of ophthalmologists is trying to ensure they can perform at their best each weekend.


John S. Grande CFP

Latest:

Planning for retirement requires balancing savings, lifestyle

It is extremely important to get a sense of confidence in your planning, because it not only affects your future, but has an impact on your life right now.


Laird Harrison

Latest:

Ophthalmologists called upon to help impaired colleagues

Ophthalmologists must take an active role in preventing impaired colleagues from hurting patients, according to Terri Pickering, MD.


Christopher R. Jarvis, MBA

Latest:

Protecting assets is top priority in malpractice climate

Regardless of the state of the malpractice insurance market, physicians always should view asset protection as an important part of their business and personal financial plan. When we use the term "asset protection," we mean shielding personal and practice assets from all potential lawsuits, including malpractice claims.


David B. Mandell, JD, MBA

Latest:

Style versus substance

Any asset protection plan that will truly stand up if challenged must have economic substance.


Noelle Creamer

Latest:

Family traditions

James C. Loden, MD, an ophthalmologist in private practice in Nashville, learned much from his father, who also was an ophthalmologist.


Pravin U. Dugel, MD

Latest:

Retinal surgeons might want to consider practicing in ASC

For more than 10 years, it has been inevitable at every meeting that a colleague will nudge me and ask in hushed tones and quivering whispers about performing retina surgery in ambulatory surgery centers (ASCs). It is much like asking for matrimonial advice from Playboy model-turned-actress Anna Nicole Smith, knowing that the advice may be tempting, but somehow immoral and unholy.


Mark Packer, MD

Latest:

The history of progress and innovation in cataract surgery

Innovations have made procedure quick, safe, effective.


Bill Gillette

Latest:

Star Search-ophthalmology edition

Smithtown, NY-The old saw "It's hard to find good help these days" may hold some truth. It's not because solid, qualified, hard-working people aren't looking for jobs. The trick, says James Rienzo, is finding them-and that takes an organized, systematic approach.


Peter J. McDonnell, MD

Latest:

(Part 1) From ophthalmology’s lockdown to lasting change: Five Aprils ago

Ophthalmologists reflect on the transformative impact of COVID-19, highlighting adaptations in patient care, safety protocols, and the rise of telemedicine.


Francis S. Mah, MD

Latest:

Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy

Mah previews a packed 2025 Annual Meeting, from the debut of SightLine to Dr. Glaucomflecken’s return to the main stage, and outlines his priorities for the year ahead as incoming ASCRS president.


Traudy F. Grande, CFPS

Latest:

Choosing your domicile state has income tax implications

Q. If your state of domicile is important to you for specific reasons, you may want to consult an attorney.


John S. Grande, CFPS

Latest:

Choosing your domicile state has income tax implications

Q. If your state of domicile is important to you for specific reasons, you may want to consult an attorney.


John J. Grande, CFPS

Latest:

Choosing your domicile state has income tax implications

Q. If your state of domicile is important to you for specific reasons, you may want to consult an attorney.


George H.H. Beiko, BM, BCh, FRCSC

Latest:

Choosing an aspheric IOL for customized results

When choosing an aspheric IOL, aiming for an overall postoperative spherical aberration of +0.10 ?m provides better patient outcomes based on the latest research.


Sherif Amer, MD

Latest:

Hypothesis may explain clinical scenarios in increased ICP

Editor's Note: Sherif Amer, MD, proposes a new hypothesis for pressure dissociation in optic disc edema due to increased intracranial pressure (ICP) (i.e., papilledema). This theory provides some insight into some of the clinically controversial scenarios that occur in increased ICP such as pseudotumor cerebri without papilledema, asymmetric or frankly unilateral papilledema, and progressive visual loss due to increased ICP without disc edema. The theory has merit and deserves further study and testing of the hypotheses generated. -- Andrew G. Lee, MD


Norman B. Medows, MD

Latest:

Retinal detachment surgery book becomes a classic

Spain-home of Toledo and some of the finest sword-makers in history, and home to the Alhambra and such people as Gaudi and Christopher Columbus-also lays claim to manyof history's most important ophthalmic families. The Barraquer family comes to mind, but there are others, including the Arruga family, which is the subject of this month's vignette.



Jennifer A. Palombi, OD

Latest:

Ophthalmologists relying on optometrists in the office

With daily operating costs rising, reimbursement rates declining, and concerns over soaring liability insurance prices, profitability is a hot topic for the modern ophthalmology practice. Some groups are finding an effective solution in the symbiosis between ophthalmology and optometry. By adding optometrists to their staffs, ophthalmologists are offering a more complete vision-care package to their patients and driving up profits in the process. The advantages, as seen by the doctors involved in these relationships, are many.

© 2025 MJH Life Sciences

All rights reserved.